Metabolic Phenotyping and Seahorse Analysis Service

We report rates, the assumptions behind each derived parameter, and the normalisation.

Assay menu

AssayInjectionsReportsTypical use
Mito Stress TestOligomycin, FCCP, rotenone/antimycin ABasal, ATP-linked, maximal, spare capacity, proton leakMitochondrial function
Glycolysis Stress TestGlucose, oligomycin, 2-DGBasal acidification, glycolytic capacity, reserveGlycolytic response
ATP Rate AssayOligomycin plus rotenone/antimycin AMitochondrial and glycolytic ATP production ratesATP source split
Substrate oxidationEtomoxir or BPTES plus uncouplerFatty acid and glutamine dependence of respirationSubstrate preference
Real-time samplingNoneGlucose, lactate, glutamine in medium over timeNet exchange

Important distinction. The Glycolysis Stress Test reports extracellular acidification, not glycolytic rate. Acidification includes a respiratory CO₂ contribution, so the "glycolytic" parameters are conditional. We report the raw ECAR values alongside the derived parameters, and we recommend lactate measurement when the claim is about glycolysis itself.

Sample types and what each requires

SampleRequirementConstraint
Adherent cells70–90% confluence, even seedingEdge effects; density-dependent baseline
Suspension cellsImmobilisation with Cell-Tak or matrixThe coating is a variable; report it
SpheroidsSize-matched, 300–500 µmThe measured rate includes a diffusion gradient
Isolated mitochondriaFresh, protein-quantifiedNot comparable to intact-cell rates
Permeabilised cellsDigitonin titrationThe permeabilisation itself must be validated

The third row is the one where clients most often expect more than the assay can give: a spheroid value is an average over a hypoxic core and a normoxic rim, and we report size distribution with the result.

Normalisation

OptionWhen we use itCaveat
Cell count at assay endDefaultRequires a terminal count in the same well
DNA contentProliferating cells, variable sizeSensitive to cell-cycle shift
ProteinOnly where protein per cell is stableMoves with lipid loading and activation
Citrate synthase activityMitochondrial content correctionSeparates "more organelles" from "better organelles"

We report the primary rate per well, then the normalised value, then the normalisation method. A rate without a stated denominator is not comparable across conditions, and most published discrepancies come from this step rather than from the measurement.

What you receive

  • • Raw OCR and ECAR per well, with the injection log and timestamps.
  • • Derived parameters, each with the assumption used in its calculation stated in a footnote.
  • • Terminal normalisation data for every well.
  • • A plate map, the assay medium composition, and the raw instrument file.
  • • A short note on anything that failed QC, including wells excluded and why.

What we do not do

  • • Report a glycolytic rate from ECAR alone. We report acidification and say so.
  • • Report maximal respiration without an FCCP titration for the cell type and day.
  • • Compare plates without a bridge sample. Instrument and plate variability is real; a bridge condition on each plate is the control.
  • • Infer dependency from a rate. A higher OCR is a rate, not a requirement; that needs a restriction experiment.

Turnaround

StageWorking days
Cell expansion and QC5–10 (client-dependent)
Assay optimisation (first time in a new background)5–10
Assay run and analysis3–5 per plate set

Typical project: 3–5 weeks from receipt of cells, including a titration plate.

What we need from you

  1. Cell type, passage, medium and mycoplasma status.
  2. The question, in one sentence — a rate question and a dependency question need different plates.
  3. Whether the readout must be per cell or per mitochondrial content.
  4. The treatments and their timing relative to the assay.

Where this connects

  • • Glucose pillar supplies the ECAR and OCR interpretation rules this service follows.
  • • Mitochondrial pillar supplies the derived-parameter assumptions.
  • • The self-assessment scores the readout type; if that row is low, an assay on this menu will not fix it, and we will say so before quoting.

Selected references for further reading

  • • Mookerjee SA, Gerencser AA, Nicholls DG, Brand MD. Quantifying intracellular rates of glycolytic and oxidative ATP production. Journal of Biological Chemistry. 2017;292:7189–7207.
  • • Divakaruni AS, Jastroch M. A practical guide for the analysis, standardization and interpretation of oxygen consumption measurements. Nature Metabolism. 2022;4:978–994.
  • • Brand MD, Nicholls DG. Assessing mitochondrial dysfunction in cells. Biochemical Journal. 2011;435:297–312.

Related Products

Product name Cat.No. Species Gene ID
PBRM1 Knockout A-549 Cell Line EDJ0001-K01 Human 55193 Details Get a Quote
YTHDC1 Knockout A-549 Cell Line EDC07652 Human 91746 Details Get a Quote
TP53 Knockout HCT 116 Cell Line EDC07854 Human 7157 Details Get a Quote
Sirt2 Knockout MH-S Cell Line EDJ-KQ78173 Mouse 64383 Details Get a Quote
TFE3 Knockout KGN Cell Line EDJ-KQ48 Human 7030 Details Get a Quote
Stub1 Knockout MB49 Cell Line EDJ-KQ53 Mouse 56424 Details Get a Quote
ARID1A Knockout SNK-6 Cell Line EDJ-KQ64 Human 8289 Details Get a Quote
Tet1 Knockout Kupffer Cell Line EDJ-KQ88 Mouse 52463 Details Get a Quote
NR1H3 Knockout HEK293T Cell Line EDJ-KQ109 Human 10062 Details Get a Quote
NR1H2 Knockout HEK293T Cell Line EDJ-KQ110 Human 7376 Details Get a Quote
RPS6KB2 Knockout HEK293 Cell Line EDJ-KQ125 Human 6199 Details Get a Quote
SMAD6 Knockout HEK293 Cell Line EDJ-KQ126 Human 4091 Details Get a Quote
JUN Knockout HEK293 Cell Line EDJ-KQ176 Human 3725 Details Get a Quote
JUN Knockout HEK293T Cell Line EDJ-KQ184 Human 3725 Details Get a Quote
ALKBH5 Knockout HEK293 Cell Line EDJ-KQ186 Human 54890 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: